组织工程医疗产品 第15部分：评价基质及支架免疫反应的试验方法：淋巴细胞增殖试验组织工程医疗产品 第15部分：评价基质及支架免疫反应的试验方法：淋巴细胞增殖试验Tissue engineered medical products—Part 15:Standard practice for evaluation of immune responses of substrate and scaffolds products:Lymphocyte proliferation tests
组织工程医疗产品 第14部分：评价基质及支架免疫反应的试验方法：ELISA法
Tissue engineered medical products—Part 14:Standard practice for evaluation of immune responses of substrate and scaffolds products:ELISA tests
2014-06-17
YY/T 0606.15-2023
组织工程医疗产品 评价基质及支架免疫反应的试验方法:淋巴细胞增殖试验
Tissue engineered medical products—Standard practice for evaluation of immune responses of substrate and scaffolds products:Lymphocyte proliferation tests
2023-01-13
YY/T 0606.20-2014
组织工程医疗产品 第20部分：评价基质及支架免疫反应的试验方法：细胞迁移试验
Tissue engineered medical products—Part 20:Standard practice for evaluation of immune responses of substrate and scaffold products:Cell migration tests
2014-06-17
YY/T 1576-2017
组织工程医疗器械产品 可吸收生物材料植入试验
Tissue engineering medical device products—Standard practice for implantation assessment of absorbable/resorbable biomaterials
2017-08-18
YY/T 0606.13-2008
组织工程医疗产品 第13部分：细胞自动计数法
Tissue engineered medical product—Part 13:Standard test method for automated enumeration of cell suspensions
2008-04-25
YY/T 1679-2021
组织工程医疗器械产品 骨 体内临界尺寸骨缺损的临床前评价指南
Tissue engineering medical device products—Bone—Standard guide for pre-clinical in vivo evaluation in critical size segmental bone defects
2021-03-09
ISO/TS 24560-1-2022
Tissue-engineered medical products — MRI evaluation of cartilage — Part 1: Clinical evaluation of regenerative knee articular cartilage using delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) and T2 mapping
组织工程医疗产品.软骨的MRI评估.第1部分:使用软骨延迟钆增强MRI（dGEMRIC）和T2成像对再生膝关节软骨的临床评估